Sort   by:  
 Page size 
UnknownVericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial.
Not available
S-EPMC9773767 | biostudies-literature
UnknownAdjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
Not available
S-EPMC2453649 | biostudies-literature
UnknownHow much is too much? Outcomes in patients using high-dose insulin glargine.
Not available
S-EPMC4738456 | biostudies-literature
UnknownClinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation.
Not available
S-EPMC10425717 | biostudies-literature
UnknownNivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
Not available
S-EPMC6824124 | biostudies-literature
UnknownA novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer.
Not available
S-EPMC6341578 | biostudies-literature
UnknownProstate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
Not available
S-EPMC8361965 | biostudies-literature
UnknownCollagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis.
Not available
S-EPMC7541088 | biostudies-literature
UnknownSafety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study.
Not available
S-EPMC12803652 | biostudies-literature
UnknownAn Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast Tumors.
Not available
S-EPMC8833410 | biostudies-literature
Sort   by:  
 Page size